(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.
about
Treating adults with acute lymphocytic leukemia: new pharmacotherapy options.Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study.Immunotherapy approaches to treat adult acute lymphoblastic leukemia.Emerging biological therapies to treat acute lymphoblastic leukemia.Hyper-CVAD + epratuzumab as a salvage regimen for younger patients with relapsed/refractory CD22-positive precursor B-cell acute lymphocytic leukemia.Emerging role of immunotherapy in precursor B-cell acute lymphoblastic leukemia.CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.
P2860
Q30243925-F7CFD756-D337-40FA-834F-534DFFDF656CQ37575938-95397CC5-EA92-43DD-9CA1-ADCB2BA13600Q38787405-99E6B5EA-E849-4903-8560-2BAB8BBFCC18Q39002036-AEEC02D0-8AD8-40EE-816D-94A3A59CE821Q42336339-EC5A6702-E725-4005-A24D-03B3D1BB0C38Q48192887-E86E75AE-0AB8-4C67-ADA3-331B00E82561Q48272279-7C8CA056-9192-4C7B-8663-3D212D4F6734Q50149863-4ECAFCA9-BEC9-4693-8B02-49D898D52EB1
P2860
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
(90)Y-labelled anti-CD22 eprat ...... phase 1 dose-escalation study.
@en
type
label
(90)Y-labelled anti-CD22 eprat ...... phase 1 dose-escalation study.
@en
prefLabel
(90)Y-labelled anti-CD22 eprat ...... phase 1 dose-escalation study.
@en
P2093
P1476
(90)Y-labelled anti-CD22 eprat ...... phase 1 dose-escalation study
@en
P2093
Alain Faivre-Chauvet
Antoine Marcais
Caroline Bodet-Milin
Claire Le Houerou
David M Goldenberg
Franck Nicolini
Françoise Huguet
Françoise Isnard
Françoise Kraeber-Bodéré
Jacques Barbet
P304
P356
10.1016/S2352-3026(15)00020-4
P577
2015-02-25T00:00:00Z